The first cancer clinical trial currently underway at UT Health San Antonio Multispecialty and Research Hospital is exploring an innovative approach researchers believe could change the future of cancer treatment.
In an interview with Texas Public Radio, Jessica Treviño Jones, MD, a breast medical oncologist at Mays Cancer Center shared insights to the Phase 2 study of an investigational therapy called STAR0602. The trial is testing an immunotherapy designed not only to attack cancer, but also to help the patient's immune system recognize it and continue responding over time.
The concept of a therapy building lasting immune “memory” is what sets this research apart. The goal is to move beyond treatments that only work in the moment and instead help the body continue fighting cancer even after therapy ends.
This first inpatient study marks a major expansion of UT Health San Antonio’s research capabilities. The seamless collaboration now possible between outpatient care at Mays Cancer Center and inpatient care at UT Health San Antonio Multispecialty and Research Hospital allows clinicians, researchers and care teams to directly provide the full spectrum of monitoring, treatment and support for patients participating in clinical trials. UT Health San Antonio's growing clinical trial capabilities are bringing new hope and the promise of a healthier future closer than ever.
Read the Full Story
Hear from the researcher in the full story from Texas Public Radio.